Clinical Trial Update: Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery [Phase 2]

View source ↗

Summary

Phase 2 safety study of aminolevulinic acid to improve visualization of brain tumors during surgery (glioblastoma) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Aminolevulinic acid (5-aminolevulinic acid)

Snippet

Sponsor: Matthew R Quigley | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED